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Xuedong Yang1, Cangsong Xiao2, Mei Liu3 and Yu Wang1*Abstract
Inflammatory myofibroblastic tumor is currently considered to be a low-grade neoplasm, and it rarely involves the
heart. We reported a rare case of a 59-year-old female who received cardiac surgery for complete resection of
inflammatory myofibroblastic tumor in the left atrium. Five months after surgery, the patient presented with acute
cardiogenic pulmonary edema and subsequent sudden death due to a left atrial tumor which protruded into the
left ventricle through mitral annulus during diastole. The recurrence of inflammatory myofibroblastic tumor in the
left atrium was strongly suggested clinically.
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Inflammatory myofibroblastic tumor (IMT) occurs
mostly in children and young adults [1] and usually
involves the lungs and gastrointestinal tract; it rarely
involves the heart. Since the first report of the cardiac
involvement of IMT in 1975 [2], there have been only a
few additional reports, and sudden unexpected death
due to cardiac IMT has rarely been reported in the med-
ical literature [3,4]. When in the heart, IMT are polypoid
masses with little myocardial infiltration, and there
seems to be no particular site predilection in the heart
other than endocardial location. Since cardiac IMT may
be potentially fatal if a cardiac valve or the coronary ar-
teries are involved, whenever feasible, complete surgical
resection of the tumor remains the mainstay of treat-
ment and seems to have a satisfactory outcome. How-
ever, the possibility of recurrence and the long-term
prognosis after cardiac surgery have not been deter-
mined due to the rarity of these lesions and to the scant
knowledge of their pathogenesis.
A 59-year-old Chinese female was hospitalized because
of exertional dyspnea for 2 weeks. Transthoracic echo-
cardiography showed a left atrial mass (Figure 1A).* Correspondence: biomelvin@gmail.com
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reproduction in any medium, provided the orCoronary angiography revealed normal coronary arter-
ies. She underwent cardiac surgery for resection of a
6.0 × 4.0 × 2.2 cm mass in the left atrium, which origi-
nated from the posterior wall of the left atrium between
pulmonary vein ostia. Histological examination of the
resected mass showed spindle cells and stroma infil-
trated with abundant lymphocytes and plasma cells.
Immunohistochemistry studies demonstrated positive
for vimentin and smooth muscle actin, and negative for
CD31, CD34 and desmin in spindle cell components
(Figure 2), which was consistent with IMT. One week
after cardiac surgery, echocardiography showed no mass
in the left atrium. After discharge, she did not receive
medical follow-up. Five months later, she presented to
the emergency department with complaint of sudden
onset of orthopnea and wheezing. She was rehospitalized
for acute pulmonary edema. Bedside transthoracic echo-
cardiography revealed a left atrial mass (3.2 × 3.1 cm)
attached to the left atrial wall, which protruded into the
left ventricle through mitral annulus during diastole and
back to the left atrium during systole (Figure 1B). No
pericardial effusion, left ventricular hypertrophy, or left
ventricular segmental wall motion abnormalities were
revealed. The ejection fraction was normal. Cardiac sur-
gery for resection of the left atrial mass was scheduled.
However, the patient was found unresponsive the day
after rehospitalization. She was resuscitated but thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Transthoracic echocardiography revealed a left atrial mass (5.5 × 2.8 cm) before cardiac surgery (A), and a left atrial mass
(3.2 × 3.1 cm) five months after surgical resection (B).
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hours after rehospitalization. The relatives of the patient
refused autopsy.
Up to now, the pathogenesis of IMT remains unclear, al-
though it is thought to be an abnormal and exaggerated
immunologic response by proliferated spindle cells and pri-
mary myofibroblasts to injury, inflammation, and infection.
The diagnosis of IMT can be difficult due to the wide mor-
phological spectrum. Coffin et al. have classified the histo-
logical findings of extrapulmonary IMT into three patterns:
(a) spindle cells in a myxoid background with a vascular
and inflammatory component resembling nodular fasciitisFigure 2 Histological examination of the resected mass in the left atr
abundant lymphocytes and plasma cells (A; H&E× 100); spindle cells
are positive for smooth muscle actin (C) and vimentin (D) immunostain.(myxoid/vascular pattern); (b) compact spindle cells with
intermingled inflammatory cells resembling fibrous histio-
cytoma (compact spindle cells pattern); and (c) dense plate-
like collagen resembling a desmoid or scar (hypocellular fi-
brosis pattern) [5]. In the present case, the histological find-
ings of the resected cardiac mass presented as the myxoid/
vascular pattern. Most of the spindle cells have the charac-
teristics of myofibroblasts, and the immunohistochemical
profile of reaction with vimentin in 99% and smooth
muscle actin in 92% is typical of this phenotype [6]. The
differential diagnosis of IMT comprises spindle cell sar-
coma and inflammatory fibrosarcoma. Sarcoma is the mostium showed bland spindle cells and stroma infiltrated with
have mild atypia with rare mitosis (B; H&E× 400). The spindle cells
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spindle cells lack the cytologic atypia and nuclear hyper-
chromasia of sarcoma, and the immunohistochemical pro-
file of myofibroblasts help to rule out spindle cell sarcoma.
It can be difficult to distinguish IMT from inflammatory
fibrosarcoma; both are included in the same section in
World Health organization classification. Inflammatory
fibrosarcoma is a locally aggressive, potentially metastasiz-
ing myofibroblastic tumor that occurs predominantly in
the mesentery and retroperitoneum of children and young
adults [7,8]. Inflammatory fibrosarcoma is now considered
indistinguishable from, and within the morphological
spectrum of, IMT [9]. Since cardiac involvement of inflam-
matory fibrosarcoma has not been reported, cardiac IMT
was diagnosed in the present case.
IMT is considered a low-grade neoplasm. The recent
classification of the World Health Organization recog-
nized the uncertainty of its biological nature, that is, its
clinical features might resemble malignant neoplasia.
Whenever feasible, complete surgical resection remains
the mainstay of treatment. Up to now, the recurrence
rate of pulmonary IMT is low. However, local recurrence
rate of extrapulmonary IMT is up to 25 % [6]. To the
best of our knowledge, only one case of recurrent car-
diac IMT has been reported [10]; IMT recurred at the
right ventricular outflow tract in a 5-month-old infant.
In the present case, the 59-year-old patient presented
with acute pulmonary edema and subsequent sudden
death due to a left atrial tumor five months after
complete surgical resection of IMT in the left atrium.
The left atrial tumor extended into the left ventricle
through the mitral annulus, causing obstruction at the
left ventricular inlet followed by acute pulmonary edema
and decreased cardiac output. In spite of lack of autopsy
evidence, the recurrence of left atrial IMT was strongly
suggested clinically. The present case suggested that, al-
though cardiac IMT was usually thought to be low-grade
neoplasm and generally did not recur after complete sur-
gical resection, given the potential catastrophic sequel of
cardiac IMT, it was strongly recommended that the
patients should be closely followed up including regular
echocardiography, even if they were asymptomatic after
surgical resection of cardiac IMT.Abbreviations
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